Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-10-30
2007-10-30
McGarry, Sean (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S006120, C435S375000, C435S377000, C536S023100, C536S024100, C536S024500
Reexamination Certificate
active
10983392
ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of Survivin. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Survivin. Methods of using these compounds for modulation of Survivin expression and for treatment of diseases associated with expression of Survivin are provided.
REFERENCES:
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 6165788 (2000-12-01), Bennett et al.
patent: WO 98/22589 (1998-05-01), None
patent: WO 98/30722 (1998-07-01), None
Ambrosini et al., “Induction of Apoptosis and Inhibition of Cell Proliferation by Survivin Gene Targeting,”J. Biol. Chem., 273:11177-11182 (1996).
Genbank Accession No. AW247335 (Dec. 16, 1999).
Grossman et al., “Expression of the Apoptosis Inhibitor, Survivin, in Nonmelanoma Skin Cancer and Gene Targeting in a Keratinocyte Cell Line,”Laboratory Investigation, 29:1121-1126 (1999).
Li et al., “Pleiotropic Cell-Division Defects and Apoptosis Induced by Interference with Survivin Function,”Nature Cell Biology, 1:461-466 (1999).
European Supplementary Search Report. European Application No. EP 01 90 8740.
Branch, A.D., “A Good Antisense Molecule is Hard to Find,”TIBS 23, 45-50 (1998).
Jen et al., “Suppression of Gene Expression by Targeted Disruption of Messenger RNA: Available Options and Current Strategies,”Stem Cells, 18, 307-319 (2000).
Adida et al., “Anti-apoptosis Gene, Survivin, and Prognosis of Neuroblastoma,”Lancet, 351:882-883 (1998).
Ambrosini et al., “A Novel Anti-apoptosis Gene, Survivin, Expressed in Cancer and Lymphoma,”Nat. Med., 3:917-921 (1997).
Cohen, G.M., “Caspases: The Executioners of Apoptosis,”Biochem. J., 326:1-6 (1997).
Lu et al., “Expression of a Novel Antiapoptosis Gene, Survivin, Correlated with Tumor Cell Apoptosis and p53 Accumulation in Gastric Carcinomas,”Cancer Res., 58:1808-1812 (1998).
Altieri, D., “Xa Receptor ERP-1,”FASEB, 9:860-865 (1995).
Altieri, D., “Splicing of Effector Cell Protease Receptor-1 mRNA is Modulated by an Unusual Retained Intron,”Biochemistry, 33:13848-13855 (1994).
Li, F., et al., “Control of apoptosis and mitotic spindle checkpoint by surviving”,Nature, 1998 386: 580-584.
Matzura, et al., “RNA draw: an integrated program for RNA secondary structure calculation and analysis under 32-bit Microsoft Windows,”Comput. Appl. Biosci.12(3):247-249 (1996).
Olie, et al., “A Novel Antisense Oligonucleaotide Targeting Survivin Expression Induces Apoptosis and Sensitizes Lung Cancer Cells to Chemotherapy,”Cancer Research60:2805-2809 (Jun. 2000).
Scherer, et al., “Approaches for the sequence-specific knockdown of mRNA,”Nature Biotechnology21(12):1457-1465 (2003).
Mahato, et al., Modulation of gene expression by antisense and entigene oligodeoxynucleotides and small interfering RNA,Expert Opinion on Drug Delivery,2(1):3-28 (2005).
Groothuis, “The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery.”Neuro-Oncology2(1):45-59 (2000).
Crooke, S.T., “Progress in Antisense Technology,”Annual Review of Medicine: Selected Topics in the Clinical Science,55:61-95 (2004).
GenBank record for accession No. L32866. Dec. 13, 1994.
Ackermann Elizabeth J.
Bennett C. Frank
Cowsert Lex M.
Cohen Charles E.
Desai Manisha A.
Isis Pharmaceuticals , Inc.
McGarry Sean
LandOfFree
Antisense modulation of survivin expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense modulation of survivin expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of survivin expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3892683